Breaking News
Title Lexaria Bioscience Receives FDA Approval for Hypertension Clinical Trial with DehydraTECHCBD
Lexaria Bioscience has recently obtained FDA approval for its upcoming U.S. Phase 1b Hypertension Clinical Trial, known as HYPER-H23-1, set...
Analysts Bullish on GoodRx Holdings Inc Following Strong Q4 FY23 Results
Analysts are feeling bullish about GoodRx Holdings, Inc. (NASDAQ: GDRX) after the company's strong fourth-quarter FY23 results. GoodRx saw a...
Goldman Sachs Analyst Bonnie Herzog Issues Sell Rating on Clorox
Goldman Sachs analyst Bonnie Herzog has recently reevaluated Clorox (NYSE: CLX) and issued a Sell rating with a target price...
Empowering the Next Generation enCore Energys Education Society and Scholarship Programs
enCore Energy has unveiled a groundbreaking Education Society and Scholarship Programs to empower young leaders in the clean energy sector....
Utz Brands Analyst Scoreboard Recent Ratings and Price Targets
Utz Brands Analyst Scoreboard Update In the last three months, analysts have shared a range of perspectives on Utz Brands...
Goldman Sachs Reinstates ColgatePalmolive with Buy Rating and 93 Price Target
Goldman Sachs analyst Jason English has reinstated Colgate-Palmolive (NYSE: CL) with a Buy rating and a price target of $93,...
CSI Compressco Fiscal Year 2024 Capital Expenditure and EBITDA Forecast
As of March 1, 2024, CSI Compressco is forecasting capital expenditures for the fiscal year to fall within the range...
Mammoth Energy Services Reports Disappointing Quarterly Financial Results
Mammoth Energy Services (NASDAQ:TUSK) announced their quarterly financial results on March 1, 2024, revealing a loss of $(0.12) per share....
HC Wainwright Co Reiterates Buy Rating on Argenx ARGX with 451 Price Target
On March 1, 2024, analyst Douglas Tsao from HC Wainwright & Co. reiterated a Buy rating on argenx (NASDAQ: ARGX)...
Title Cullinan Oncology Receives FDA Approval for Groundbreaking Cancer Therapy with CLN619 Antibody
Cullinan Oncology has just received the green light from the FDA for its groundbreaking Investigational New Drug Application for the...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
